PodParley PodParley
PodParley
Randomized Phase 3 Trial of Neoadjuvant Durvalumab plus Chemotherapy Followed by Radical Cystectomy and Adjuvant Durvalumab in Muscle-Invasive Bladder Cancer - report from ESMO2024 episode artwork

EPISODE · Oct 24, 2024 · 4 MIN

Randomized Phase 3 Trial of Neoadjuvant Durvalumab plus Chemotherapy Followed by Radical Cystectomy and Adjuvant Durvalumab in Muscle-Invasive Bladder Cancer - report from ESMO2024

from Medical Digest & Congress Report · host Medical Congress News

Professor Petros Grivas shares his insights on the NIAGARA study. Video: https://medicaldigest.org/scientific-contents/interview:randomized-phase-3-trial-neoadjuvant-durvalumab-plus-chemotherapy-followed-radical-cystectomy-and-adjuvant-durvalumab-muscle-invasive-bladder-cancer

Episode metadata supplied by the publisher feed · Published Oct 24, 2024

Embed this episode

Ready to play

Randomized Phase 3 Trial of Neoadjuvant Durvalumab plus Chemotherapy Followed by Radical Cystectomy and Adjuvant Durvalumab in Muscle-Invasive Bladder Cancer - report from ESMO2024

0:00 4:17

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 4 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on October 24, 2024.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!